BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18182852)

  • 1. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.
    Kee SK; Lee JY; Kim MJ; Lee SM; Jung YW; Kim YJ; Park JY; Bae HI; Hong HS; Yun YK; Kim SG; Kim DS
    Mol Cells; 2007 Dec; 24(3):364-71. PubMed ID: 18182852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Yamada S; Ishizuka A; Mizusawa N; Horiguchi H; Hirokawa M; Asa SL
    Lab Invest; 2005 Apr; 85(4):464-73. PubMed ID: 15711568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
    Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G
    J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
    Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
    Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features.
    Lee YM; Lee JY; Kim MJ; Bae HI; Park JY; Kim SG; Kim DS
    Cancer Sci; 2006 Nov; 97(11):1205-10. PubMed ID: 16965602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
    Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
    Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras mutations and RASSF1A promoter methylation in colorectal cancer.
    van Engeland M; Roemen GM; Brink M; Pachen MM; Weijenberg MP; de Bruïne AP; Arends JW; van den Brandt PA; de Goeij AF; Herman JG
    Oncogene; 2002 May; 21(23):3792-5. PubMed ID: 12032847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.
    Zhu X; Yang H; Lang J; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():103-108. PubMed ID: 31242460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
    Dammann R; Yang G; Pfeifer GP
    Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma.
    Guo W; Dong Z; Chen Z; Yang Z; Wen D; Kuang G; Guo Y; Shan B
    Cancer Invest; 2009 May; 27(4):459-65. PubMed ID: 19160099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.
    Pallarés J; Velasco A; Eritja N; Santacana M; Dolcet X; Cuatrecasas M; Palomar-Asenjo V; Catasús L; Prat J; Matias-Guiu X
    Mod Pathol; 2008 Jun; 21(6):691-9. PubMed ID: 18469797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
    Jezkova E; Kajo K; Zubor P; Grendar M; Malicherova B; Mendelova A; Dokus K; Lasabova Z; Plank L; Danko J
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27744628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China.
    Zhou SL; Cui J; Fan ZM; Li XM; Li JL; Liu BC; Zhang DY; Liu HY; Zhao XK; Song X; Wang R; Yan ZC; Yi HX; Wang LD
    BMC Cancer; 2013 May; 13():259. PubMed ID: 23705663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.
    Li J; Zhang Z; Dai Z; Popkie AP; Plass C; Morrison C; Wang Y; You M
    Neoplasia; 2003; 5(4):362-6. PubMed ID: 14511407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.